公司資料
Ambrx Biopharma 股價、新聞與催化劑
- 股票代碼:
- AMAM
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for AMAM.
公司概覽
業務概覽
Ambrx Biopharma was an antibody-drug conjugate company focused on precision oncology before being acquired by Johnson & Johnson. Its platform centered on engineered biologics and targeted payload delivery.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ before acquisition, Ambrx sat in oncology biotechnology.
商業模式特徵
The business relied on ADC development, clinical data, and the strategic value of its biologic engineering platform.
生技產業定位
Ambrx was a differentiated ADC name and now belongs to biotech M&A history.
未來催化劑
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。